1. Introduction {#sec1-molecules-23-01182}
===============

Quinolones are a group of synthetic antibacterial agents used in treatment of many infections \[[@B1-molecules-23-01182],[@B2-molecules-23-01182],[@B3-molecules-23-01182]\]. Fluoroquinolone gemifloxacin (GMFX) ([Scheme 1](#molecules-23-01182-sch001){ref-type="scheme"}A) is a synthetic broad-spectrum antibacterial agent \[[@B4-molecules-23-01182]\] used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. GMFX has excellent in vitro activity against both Gram-positive (G+ve) and Gram-negative (G−ve) organisms, including potent antibacterial activity against respiratory tract infection pathogens \[[@B4-molecules-23-01182],[@B5-molecules-23-01182]\]. GMFX acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV, which are essential for bacterial growth. Fluoroquinolone antibiotics have also been found to have anti-inflammatory and anticancer effects. Recently, some experiments were carried out and revealed that GMFX has an anticancer effect on colon cancer via inhibition of metastasis \[[@B6-molecules-23-01182]\]. The interaction of metal ions with diverse deprotonated fluoroquinolones has been thoroughly studied \[[@B7-molecules-23-01182],[@B8-molecules-23-01182]\]. In many cases, the metal complexes of drugs are more active than the parent compound \[[@B8-molecules-23-01182],[@B9-molecules-23-01182]\].

From this point of view, diverse metal complexes with fluoroquinolones have been synthesized in an attempt to investigate the physicochemical properties and evaluate their biological properties \[[@B10-molecules-23-01182],[@B11-molecules-23-01182]\] and potential antitumor activity in comparison with free fluoroquinolones \[[@B12-molecules-23-01182],[@B13-molecules-23-01182],[@B14-molecules-23-01182]\]. Mixed ligand complexes play an important role in biological processes as exemplified by many instances in which enzymes are known to be activated by metal ions \[[@B11-molecules-23-01182],[@B12-molecules-23-01182],[@B13-molecules-23-01182],[@B14-molecules-23-01182],[@B15-molecules-23-01182],[@B16-molecules-23-01182],[@B17-molecules-23-01182]\]. A good number of metal mixed-ligand complexes containing glycine (Gly) ([Scheme 1](#molecules-23-01182-sch001){ref-type="scheme"}B) with some other ligand are reported in the literature \[[@B18-molecules-23-01182]\] where the Gly amino acid acts as bidentate ligand coordinating through the carboxylate oxygen and the amino nitrogen with octahedral geometry for metal chelates. The aim of the present work is to study the effect of changing atomic volume, atomic mass, and oxidation state of some metal ions (Zn(II), Sn(II), Ce(III)) with Cl^−^ as counter ion on the biological activity of gemifloxacin as antibacterial agent in the presence of Gly and to examine the mode of coordination and the biological properties of the resulting complexes. The synthesized complexes were characterized physicochemically by melting point, molar conductivity, magnetic property, elemental, infrared (IR), ultraviolet-visible (UV--Vis) and proton-nuclear magnetic resonance (^1^H NMR).

The biological characterization of GMFX and its synthesized metal complexes was carried out by an antifungal activity test activity against some phytopathogenic fungi such as; *Rhizoctonia solani* J.G. Kühn., *Sclerotinia sclerotiorum* (Lib.) de Bary., *Aspergillus niger* van Tieghem., *Botrytis cinerea* Pers., and *Penicillium digitatum* Sacc. On the other hand, the bactericidal effect of the above mentioned substances was performed against two G+ve bacteria *Xanthomonas campestris* Pammel and *Bacillus megaterium* de Bary and two G−ve bacteria *Escherichia coli* Migula and *Clavibacter michiganensis* Smith. In addition, antioxidant activity test has been also carried out for GMFX ligand and its synthesized metal complexes by using two different methods 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis (3-ethylbenzthiazoline-6-acid) (ABTS) for determine the radical scavenging activity (RSA%).

2. Results and Discussion {#sec2-molecules-23-01182}
=========================

GMFX reacts with Zn(II), Sn(II), and Ce(III) in the presence of Gly as secondary ligand at 100 °C in ethanol to form solid complexes. The complexes were obtained as colored powdered materials. [Table 1](#molecules-23-01182-t001){ref-type="table"} summarizes the carbon, hydrogen, and nitrogen elemental analysis as well as melting point, magnetic measurements, and molar conductance. Moreover, the synthesized complexes were characterized using elemental analysis, IR, UV-Vis and ^1^H NMR spectra analyses. The molar ratio for all prepared complexes is GMFX:M:Gly = 1:1:1 which was established from the results of the chemical analyses and all the prepared complexes were air stable solids at room temperature. The IR spectroscopic data confirm the presence of water in the composition of the complexes \[[@B18-molecules-23-01182]\] with the number of bound water molecules in these complexes being different. The structures of the complexes suggested from the elemental analysis agree quite well with their proposed formula. The metal ions are coordinated to a deprotonated carboxylate oxygen and pyridone oxygen of GMFX and Gly through the carboxylate oxygen and the amino nitrogen. Here, metal ions react with GMFX and Gly, forming complexes of monomeric structure where the metal ions are six coordinate and complete the coordination number with two water molecules ([Scheme 2](#molecules-23-01182-sch002){ref-type="scheme"}). The molar conductance values of the GMFX and their metal complexes in dimethyl formamide (DMF) with standard reference using 1 × 10^−3^ mol^−1^ solutions at room temperature were found to be in the range from 47.50 to 150.11 S cm^2^ mol^−1^. The data indicated that the complexes are electrolytes and the chloride ions were found as counter ions at all three complexes \[[@B19-molecules-23-01182],[@B20-molecules-23-01182]\]. For our complexes, in order to verify that the chloride is ionic, their solutions were tested with aqueous solutions of AgNO~3~. A white precipitate was formed which indicated the presence of Cl^−^ as counter ions. The magnetic moments (as B. M.) of the complexes were measured at room temperature. The Zn(ΙΙ) and Sn(II) complexes were found to be of diamagnetic character with octahedral molecular geometry but the complex of Ce(ΙII) is susceptible and their magnetic moments were 2.34 μ~eff~.

The chloride content in the complexes was determined by using two methods; Mohr and Volhard. The lattice water for the three complexes was determined by heating an accurate weight of each complex from the ambient temperature up to \~120 °C, the weight loss for each chelate were calculated. The weight loss of Sn(II) and Ce(III) complexes are 2.74%, and 2.46%, respectively. These data support the proposed complexes' chemical formulae and indicate the presence of one hydration water molecule for Sn(II) and Ce(III) complexes.

On the other hand, the measurement of the molar conductivity showed clear differences between the three prepared complexes (divalent and trivalent salt ions) as we have already specified in the manuscript ([Table 1](#molecules-23-01182-t001){ref-type="table"}). Based on the above explanation, there is a steady relationship between increasing the conductivity of the compound and its solubility, as has been discussed by Uivarosi \[[@B21-molecules-23-01182]\] who reported that the quinolone chelates of trivalent cations have shown an improved solubility compared to that of the free ligand and this behavior could be advantageous for pharmaceutical formulation.

2.1. Infrared Absorption Spectra {#sec2dot1-molecules-23-01182}
--------------------------------

The infrared spectra of Zn(II), Sn(II), and Ce(III) complexes and free GMFX, Gly were measured as potassium bromide (KBr) discs. These spectra are shown in [Figure 1](#molecules-23-01182-f001){ref-type="fig"} and the assignments are given in [Table 2](#molecules-23-01182-t002){ref-type="table"}. The infrared spectra of the three complexes were compared with those of the free ligands in order to determine the site of coordination that may be involved in the chelation process. These peaks were expected to be involved in chelation. The position or the intensities of these peaks were expected to be changed upon complexation. The IR spectra of the complexes were very similar due to the same atoms of GMFX and Gly involved in the bonding to the metal. In most cases, the proposed mechanism of the interaction between GMFX and the metal cations was chelation between the metal ions through pyridone and carboxylic groups; therefore, it was important to give more attention to these group vibrations. The infrared spectra of the metal complexes exhibit a broad band between 3455 and 3411 cm^−1^ which corresponds to the ν(O--H) vibration and confirms the presence of water molecules in all complexes \[[@B18-molecules-23-01182],[@B22-molecules-23-01182]\]. The two bands observed at 1720 and 1632 cm^−1^ in the spectrum of the free GMFX have been assigned to the stretching vibration of carboxylic ν(COOH) and the pyridone group ν(C=O), respectively \[[@B23-molecules-23-01182]\], and at 1703 cm^−1^ for ν(C=O) carboxyl of Gly \[[@B24-molecules-23-01182],[@B25-molecules-23-01182],[@B26-molecules-23-01182],[@B27-molecules-23-01182]\].

In the IR spectra of the complexes, the band corresponding to the carboxylic group appears with ∆ν = ν~as~(COO^−^) − ν~s~(COO^−^) \> 200 cm^−1^, indicating carboxylic group involvement in monodentate coordination \[[@B28-molecules-23-01182],[@B29-molecules-23-01182]\]. These changes in the IR spectra suggest that GMFX is bound to metal ions via the carboxylate oxygen atom \[[@B23-molecules-23-01182]\]. Also, the second important band at 1634 cm^−1^, being attributed to the pyridone group, shifted to lower values at 1575 cm^−1^ for Sn(II), 1557 cm^−1^ for Zn(II), and 1559 cm^−1^ for Ce(III) being a good indication that this group is coordinated to the metal ions \[[@B30-molecules-23-01182],[@B31-molecules-23-01182]\].

Regarding chelation through amino acids, the IR spectra exhibit significant features in the νNH~2~ and νCOO^−^ regions. It is worthwhile to mention here that free amino acids exist as zwitterions and the IR spectra of these cannot be compared entirely with those of metal complexes as amino acids in metal complexes do not exist as zwitterions. Free amino acids with NH~3~ functions in particular show νNH~3~ in the range of 3130--3030 cm^−1^. In the complexes, NH~3~ gets deprotonated and binds to metal through the neutral NH~2~ group. The transformation of NH~3~ to NH~2~ must result in an upward shift in the νNH~2~ of free amino acids. At the isoelectric point, they must show νNH~2~ in the region 3500--3300 cm^−1^ \[[@B26-molecules-23-01182]\]. In the present complexes, the IR spectra showed characteristic bands in the region of 3459--3181 cm^−1^, which are lower compared to those of free νNH~2~. Hence, it can be concluded that the nitrogen of the amino group is involved in coordination. The IR spectra show strong evidence in support of the involvement of the carboxylate group in coordination.

In comparison with free amino acids, the νCOO^−^ (asymmetric) and νCOO^−^ (symmetric) record different shifts, which confirms the monodenticity \[[@B32-molecules-23-01182]\] of the carboxylate group. The values of band shift ∆ν = ν~as~(COO^−^) − ν~s~(COO^−^) have indicated that the carboxylate group in Gly was chelated in a uni-negatively manner to the metal ions.

The spectra of the isolated solid complexes show a group of new bands with different intensities, being characteristic for ν(M--O) and ν(M--N). The ν(M--O) and ν(M--N) bands were observed at 689 and 601 cm^−1^ for Sn(II), at 692 and 642 cm^−1^ for Zn(II), at 693, 669, 640, 613, and 590 cm^−1^ for Ce(III), and being absent from the spectra of GMFX and Gly. This indicates coordination of GMFX and Gly through the pyridone, the carboxylate oxygen of GMFX, Gly, and the amino nitrogen of Gly.

2.2. Ultraviolet-Visible Spectroscopy Analysis {#sec2dot2-molecules-23-01182}
----------------------------------------------

Application of ultraviolet spectroscopy can be useful for structural determination of chelates since they all absorb in this region \[[@B24-molecules-23-01182],[@B33-molecules-23-01182],[@B34-molecules-23-01182]\]. Formation of mixed ligand complexes was confirmed by the electronic absorption spectra. The electronic absorption spectra of the ligand along with the Zn(II), Sn(II), and Ce(III) complexes from 200 to 800 nm are shown in ([Figure 2](#molecules-23-01182-f002){ref-type="fig"}). Free GMFX showed bands at 213--245 nm and 276--343 nm which may be assigned to π--π\* and *n*--π\* transitions. Respectively. The shift of the absorption bands to higher or lower values and the appearance of new bands for the complexes are attributed to the mixed ligand complexation.

The decrease or increase of the absorption bands and the appearance of new bands upon coordination could be caused by the following effects: (1) the expected increase of the metal ion mass upon coordination; (2) the increase of the electron density on the metal ions by ligand, and (3) the decrease of the electron density on oxygen and nitrogen donor atoms. The complexes of Zn(II), Sn(II), and Ce(III) showed bands in the range of 402--468 nm, which may be assigned to ligand--metal charge transfer ([Table 3](#molecules-23-01182-t003){ref-type="table"}).

2.3. Proton-Nuclear Magnetic Resonance Spectra Analysis {#sec2dot3-molecules-23-01182}
-------------------------------------------------------

The suggested molecular structures of the complexes were also proved by nuclear magnetic resonance (NMR) spectroscopy. The ^1^H NMR spectra of the ligands and their metal complexes in CD~3~OD displayed distinct signals with appropriate multiplets; the signal assignments are shown in ([Figure 3](#molecules-23-01182-f003){ref-type="fig"}). The ^1^H NMR spectrum obtained for GMFX shows peaks in the range δ = 8.02--8.72 ppm for the protons of an aromatic ring, a multiplet at δ = 1.14--1.33 ppm corresponding to --CH~2~ and --CH cyclopropane group, between 3.32 and 3.36 ppm for a --CH~2~ aliphatic group, and a singlet peak at δ = 11.0 ppm for the proton of carboxylic acid. The ^1^H NMR spectrum of glycine shows a peak at δ = 11.0 ppm for the proton of carboxylic acid and a peak at δ = 2.0 ppm for the amine ([Table 4](#molecules-23-01182-t004){ref-type="table"}).

Comparing the main signals of the complexes with those of GMFX and Gly, the ^1^H NMR spectra of the complexes showed chemical shift values that were only slightly changed compared with the free ligands, except for the carboxylic acid proton signal: the resonance of the carboxylic proton (COOH) was not detected in the spectra of the three complexes, suggesting coordination of GMFX and Gly through its carboxylation to oxygen atoms \[[@B24-molecules-23-01182],[@B25-molecules-23-01182]\]. Also, the ^1^H NMR spectra for the complexes exhibit a new peak in the range of 4.50--4.89 ppm, due to the presence of water molecules in the complexes \[[@B35-molecules-23-01182]\].

2.4. Biological Activities {#sec2dot4-molecules-23-01182}
--------------------------

### 2.4.1. Antibacterial Activity {#sec2dot4dot1-molecules-23-01182}

The results of antibacterial test showed that the tested ligands and its metal complexes were able to inhibit the growth of all studied bacterial strains in a dose dependent manner ([Table 5](#molecules-23-01182-t005){ref-type="table"}). In particular, all GMFX--metal complexes demonstrated the highest significant activity against *E. coli* at 10,000 ppm compared to all other treatments. Whereas, GMFX 10,000 ppm and its Sn and Zn complexes at 1000 ppm showed moderate activity. In contrast. GMFX at 1000 and 100 ppm and its metals complexes at 100 ppm showed the lowest significant activity against *E. coli.*

In case of the antibacterial activity against *C. michiganensis*, the obtained results showed that GMFX and all its metal complexes inhibited its growth completely at all tested concentrations. In case of *X. campestris* and *B. megaterium*, the GMFX and all its metal complexes at 10,000 ppm showed the highest significant activity compared to all other treatments. The Ce(III)--GMFX complex at 100 ppm showed the lowest significant activity. The potential antibacterial efficacy of the tested ligand and its metal complexes is thought to depend on the specific toxicity of the studied metals. The low activity observed against *E. coli*, especially at low concentrations, could be due to the presence of lipopolysaccharides in the outer membrane of the G−ve bacteria, which make them inherently resistant to external agents. Cole et al. \[[@B36-molecules-23-01182]\] have reported that the differences among G−ve and G+ve bacteria regarding the bactericidal effect are due to the structure of their cell walls, where the G−ve bacteria have a more complex cell wall composed of a thin peptidoglycan layer and an outer membrane containing lipopolysaccharides, whereas G+ve bacteria are protected by a wall predominantly composed by one type of macromolecule (pepidoglycan). The obtained results are in agreement with Sadeek et al. \[[@B37-molecules-23-01182]\] who concluded that there is a significant increase in antibacterial activity of metal complexes compared to uncomplexed ligand.

### 2.4.2. Antifungal Activity {#sec2dot4dot2-molecules-23-01182}

Results of the in vitro antifungal activity testing of the studied ligand GMFX and its metal complexes against *R. solani* and *B. cinerea* showed that GMFX at 500 and 1000 ppm demonstrated the highest significant activity compared either to all other treatments or the two tested synthetic fungicides azoxystrobin and cycloheximide ([Table 6](#molecules-23-01182-t006){ref-type="table"}). On the other hand, when the fungicidal activity against *S. sclerotiorum* was tested, the obtained results showed that azoxystrobin has significantly higher activity than GMFX. There were no significant differences between the Zn(II) and Ce(III) complexes. In the case of antifungal activity against *A. niger*, GMFX exhibited the highest significant activity at all tested concentrations and was similar to the Zn(II) complex and azoxystrobin. Regarding the activity against *P. digitatum*, GMFX at 1000 ppm and its Zn(II) complex had the highest significant activity, which was similar to both tested synthetic fungicides, and were followed by all other metal complexes.

The increased biological activity of metal chelates was explained by the concept of cell permeability and chelation theory. Upon chelation, the polarity of a metal ion is reduced due to the partial sharing of the positive charge with the donor groups of the ligand and as a consequence of overlap with the ligand orbitals. Chelation increases the delocalization of electrons over the whole chelate ring and thus increases the lipophilic nature of the central ion. This increase in lipophilicity enhances the passage of the complex through lipid membranes, facilitating the penetration of cells \[[@B38-molecules-23-01182],[@B39-molecules-23-01182],[@B40-molecules-23-01182]\].

### 2.4.3. Minimum Inhibitory Concentration of Fungicidal Activity {#sec2dot4dot3-molecules-23-01182}

Minimum inhibitory concentration (MIC) tests were carried out for the most inhibited tested fungi (*B. cinerea* and *P. digitatum*). The effects of the different concentrations of GMFX and its metal complexes against the above-mentioned fungi were variable. In particular, MIC values in the case of *B. cinerea* were evaluated by 2000 ppm in case of the Ce(III)--GMFX complex and 2100 ppm in the case of the \[Zn(II) or Sn(II)\]--GMFX complexes and uncomplexed GMFX. Regarding *P. digitatum*, the MIC values were ordered in the following manner: Sn(II)--GMFX \< Ce(III)--GMFX \< free GMFX \< Zn(II)--GMFX where the values were measured as 1400, 2100, 2200, and 2600 ppm, respectively.

### 2.4.4. Antioxidant Activity {#sec2dot4dot4-molecules-23-01182}

We have screened the antioxidant activity of GMFX and its metal complexes to evaluate their electron-donating activity. Results showed the highest significant antioxidant activity for the GMFX--Sn complex (*p* \< 0.05) ([Figure 4](#molecules-23-01182-f004){ref-type="fig"}), compared to all other treatments. In particular, the DPPH and ABTS scavenging activity evidenced that Stannum presented the best percentage of antiradical activity. These results are in accordance with Bukhari et al. \[[@B41-molecules-23-01182]\] and Chen et al. \[[@B42-molecules-23-01182]\] who reported that the antioxidant activity of some ligands was increased by the presence of metal, such as Sn(IV).

In any case, the antiradical activity of the GMFX--Sn complex could be due to its hydrogen donating ability, as reported by Corona-Bustamante et al. \[[@B43-molecules-23-01182]\]. A possible exchange mechanism is that the proton from the GMFX ligand is donated and the charge is stabilized inside the entire complex, changing its charge delocalization capacity. The high scavenging activity of the Sn complex may explain its low antimicrobial activity, since the oxygenated compounds may contribute to the attachment to and destruction of the microorganism's cell wall, hence increasing the permeability of cytoplasm fluid and finally leading to cell death.

3. Materials and Methods {#sec3-molecules-23-01182}
========================

3.1. Materials {#sec3dot1-molecules-23-01182}
--------------

All chemicals used for preparation of the complexes were of analytical reagent grade, being commercially available from different sources and used without further purification. Gemifloxacin was purchased from Obour Pharmaceutical Industrial Company (Cairo, Egypt). Glycine, AgNO~3~, K~2~CrO~4~, and ethanol (99.8%) were purchased from Fluka, Sigma Aldrich Company (Seelze, Germany). SnCl~2~·2H~2~O (98%) and ZnCl~2~ (98%) were purchased from Carlo Erba company (Milan, Italy). CeCl~3~·7H~2~O was purchased from Sigma Aldrich Company (Steinheim, Germany).

3.2. Synthesis of Mixed Ligand Metal Complexes {#sec3dot2-molecules-23-01182}
----------------------------------------------

The faint brown solid complex \[Sn(GMFX)(Gly)(H~2~O)~2~\]Cl (Complex 1) was prepared by adding 0.5 mmol (0.112 g) stannous chloride SnCl~2~·2H~2~O in 50 mL ethanol drop-wise to a stirred suspended solution of 0.5 mmol (0.194 g) GMFX and 0.5 mmol (0.037 g) glycine(Gly) in 30 mL ethanol. All reactants were boiled in reflux apparatus in stirred conditions for about 5--6 h at 100 °C in water bath. Then, the prepared complex was subjected to the rotary evaporator for 30 min at 30 °C and 270 rpm until reach the completely dried complex. The faint yellow and beige solid complexes \[Zn(GMFX)(Gly)(H~2~O)~2~\]Cl·H~2~O (Complex 2) and \[Ce(GMFX)(Gly)(H~2~O)~2~\]Cl~2~·H~2~O (Complex 3) were prepared in a similar manner by using ethanol as a solvent and ZnCl~2~ and CeCl~3~, respectively, in 1:1:1 (GMFX:M:Gly) molar ratio with 0.5 mmol of ZnCl~2~, CeCl~3~·7H~2~O, GMFX, and glycine (Gly). We were not able to obtain appropriate monocrystals to perform X-ray diffraction analysis.

Complex (1)

(7-\[(4*Z*)-3-(Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl\]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid)(aminoethanoic acid)(bihydrate) stannous chloride

Complex (2)

(7-\[(*4*Z)-3-(Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl\]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid)(aminoethanoic acid)(bihydrate) zinc chloride monohydrate.

Complex (3)

(7-\[(4*Z*)-3-(Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl\]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid) (aminoethanoic acid) (bihydrate)cerium bicholoride monohydrate.

3.3. Instruments {#sec3dot3-molecules-23-01182}
----------------

Elemental C, H, N analysis was carried out on a PerkinElmer CHN 2400 (Waltham, MA, USA). The percentage of metal ions was determined by using the atomic absorption method with a PYE-UNICAM SP 1900 spectrometer (Cambridge, UK) fit with the corresponding lamp. IR spectra were recorded from KBr discs using an FT/IR-460 Plus model Jasco-32 spectrophotometer (Easton, PA, USA) in the range from 4000 to 400 cm^−1^. ^1^H NMR spectra were recorded on a Varian 400 NMR spectrometer (Urbana, IL, USA) using CD~3~OD as solvent. Electronic spectra were obtained using T80 UV/Vis spectrometer (Taylors, SC, USA) PG Instruments Ltd. Magnetic susceptibilities of the powdered samples were measured on a Sherwood scientific magnetic balance (Cambridge, UK) using the Gouy method with Hg\[Co(SCN)~4~\] as calibrant. Molar conductance of 1 × 10^−3^ M solutions of ligand and metal complexes in DMF was measured at room temperature using a CONSORT K410 (Turnhout, Belgium). All measurements were carried out at ambient temperature with freshly prepared solutions. Melting points were recorded on a Buchi apparatus.

3.4. Antimicrobial Investigation {#sec3dot4-molecules-23-01182}
--------------------------------

### 3.4.1. Bactericidal Activity Test {#sec3dot4dot1-molecules-23-01182}

The antibacterial test of the studied ligand and its metal complexes was investigated by the disc diffusion method of Bhunia et al. \[[@B20-molecules-23-01182],[@B44-molecules-23-01182],[@B45-molecules-23-01182]\] against *X. campestris*, *B. megaterium, E. coli*, and *C. michiganensis* with some minor modifications. All strains were listed in National Collection of Plant Pathogenic Bacteria Catalogue (NCPPB) and have been cultivated, lyophilized, and freeze-conserving as pure cultures in the collection of the School of Agricultural, Forestry, Food and Environmental Sciences, University of Basilicata, Potenza, Italy. The bacterial suspension of each strain was prepared in sterile distilled water plus soft agar (0.7%) at concentration 10^8^ colony form unit (CFU) mL^−1^ (optical density, OD ≈ 0.2 nm). A mixture of 0.7% soft agar and bacterial suspension (9:1 *v*/*v*) was prepared and 4 mL of this suspension was poured into each 10 mL KB Petri dish 90 mm in diameter. Blank Discs (6 mm)-OXOID (Milan, Italy) were placed over KB-plate surfaces after complete solidification and 20 µL aliquots from each ligand and metal complexes at the following concentrations (1:5) 5000, 250, and 62.5 ppm.

### 3.4.2. Fungicidal Activity Test {#sec3dot4dot2-molecules-23-01182}

The antifungal screening was evaluated against five phytopathogenic fungi: *R. solani*, *S. sclerotiorum*, *A. niger*, *B. cinerea*, and *P. digitatum*. The tested fungi were previously identified by classical and molecular methods and stored in the mycotheca of School of Agricultural, Forestry, Food and Environmental Sciences, University of Basilicata, Potenza, Italy with the following collection numbers: *R. solani* 1312; *S. sclerotiorum* 593; *A. niger* 1008; *B. cinerea* 479, and *P. digitatum* 1395. Different concentrations of each treatment at 1000, 500, and 250 ppm was prepared in potato dextrose agar (PDA). Fourteen mL aliquots of previous prepared media supplemented with each treatment was poured into Petri dishes. After the complete dry off of the agar surface under laminar flow, 0.5 cm diameter of fungal disks square cut off from 96 h fresh cultures were singularly inoculated in the center of each Petri dish prepared as above. All plates were incubated at 24 ± 2 °C for 4 days under dark conditions. The diameter of fungal mycelium growth measured in mm. Petri dishes containing only PDA were also inoculated with fungal disks of the same fungi and used as a control. Each treatment was carried out in triplicate. The fungitoxicity was expressed as growth inhibition percentage (GIP) and calculated according to the formula of Zygadlo et al. \[[@B46-molecules-23-01182]\] (Equation (1)), herein reported. Compared to synthetic fungicide azoxystrobin 1 µL mL^−1^ and cycloheximide 0.1 µg mL^−1^ to PDA nutrient medium: where: GC = average diameter of fungus colony grown on PDA alone (control); GT = average diameter of fungus colony grown on PDA containing each treatment.

### 3.4.3. Determination of Minimum Inhibitory Concentration (96-Well Microplate Method) {#sec3dot4dot3-molecules-23-01182}

The MIC was considered as the fungicidal effect of each treatment, defined as the lowest concentration of each ligand and metal complexes that definitely inhibits the fungal growth. MIC was determined on 96-well culture plates by a micro-dilution method following the technical procedures of Lehtinen et al. \[[@B47-molecules-23-01182]\]. Spore formation was ascertained after nine days incubation under a light microscope (Axioskop, ZEISS, West Germany). The stock solution of each treatment was prepared in Potato Dextrose Broth (PDB) at 1000, 1200, 1400, 1600, 1800, 2000, 2200, 2400, 2600, 2800, and 3000 µg mL^−1^. The absorbance of fungal growth was read at λ = 450 nm using the Elisa Microplate reader instrument (DAS s.r.l., Rome, Italy). All samples were tested in triplicate.

### 3.4.4. Antioxidant Activity {#sec3dot4dot4-molecules-23-01182}

In the present study, two tests were performed (ABTS and DPPH) following the methodological procedures of the basic principles of Martysiak-Żurowska and Wenta \[[@B48-molecules-23-01182]\], as follows. In these trials, the above mentioned two assays were carried out to determine the radical scavenging activity (RSA%) of the studied ligand and its metal complexes at 100% utilizing the following formula: where A~t~ is the absorbance of sample and A~c~ is the absorbance of colorimetric radical substance without sample.

#### DPPH: 2,2-diphenyl-1-picrylhydrazyl Assay

The DPPH method is considered one of the most useful techniques for measuring the antiradical activity of a compound and it depends on the use of the stable free radical DPPH. The electronic delocalization of this radical is responsible for its characteristic deep violet color and hence the compounds which will be able to donate a hydrogen atom will convert the DPPH radical into its reduced form (neutral stable molecule) and then the color switch from deep violet to pale yellow \[[@B49-molecules-23-01182],[@B50-molecules-23-01182]\]. Stock radical solution (DPPH solution) was prepared by dissolving 20 mg of DPPH in 15 mL of ethanol. Thereafter, 1 mL of DPPH solution was diluted with 29 mL of ethanol.

Test procedures: 50 µL was diluted at (1:20) using 950 µL of DPPH solution and was incubated at darkness for 30 min at room temperature. Later on, all samples were centrifuged at 8000 rpm for 5 min and the absorbance was measured at 515 nm in triplicate using a UV-Vis spectrophotometer (LKB Biochrom 4050 Ultrospec II, Arizona, USA) considering the value of the reference sample (ethanol). The stock solution of DPPH was prepared fresh and all determinations were carried out in triplicate.

#### ABTS: 2,2′-azinobis (3-ethylbenzthiazoline-6-acid) Assay

The ABTS method is considered the most sensitive method and is characterized by higher repeatability for observing the kinetics of specific enzymes. The detectability and sensitivity of ABTS are higher than the DPPH assay.

Stock radical solution. ABTS solution was prepared by dissolving 38 mg of ABTS in 10 mL of a aqueous sodium persulphate solution (2.45 mM). and the solution was conserved in darkness for 16 h at room temperature. Then, 1 mL of stock ABTS^•+^ solution was diluted with 29 mL of ethanol.

Test procedures: 20 µL of each studied ligand and the metal complexes was diluted at (1:50) using 980 µL of radical ABTS^•+^ solution and was incubated after that in darkness at room temperature for 2 h. All samples were centrifuged at 8000 rpm for 5 min and the absorbance was measured at 734 nm by using UV-Vis spectrophotometer (LKB Biochrom 4050 Ultrospec II) considering the value of reference sample (ethanol). The stock solution of ABTS was prepared fresh and all determinations were carried out in triplicate.

3.5. Statistical Analysis {#sec3dot5-molecules-23-01182}
-------------------------

The outcomes of the biological tests were statistically analyzed using statistical package for the social sciences (SPSS) (version 13.0. Prentice Hall, Chicago, IL, USA, 2004). Experimental data were expressed as mean ± SD and comparisons were employed by Tukey post-hoc test for detecting any significance differences among different treatments at *p* \< 0.05.
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![(**A**). 7-\[(4*Z*)-3-(Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl\]-1-cyclopropyl-6-fluoro-4-oxo-1.8-naphthyridine-3-carboxylic acid (GMFX) and (**B**) amino acetic acid (Gly).](molecules-23-01182-sch001){#molecules-23-01182-sch001}

![The coordination mode of Zn(II), Sn(II), and Ce(III) with mixed ligands. M = Zn(II), Sn(II), and Ce(III). *n* = 1 for Zn(II), Sn(II). *n* = 2 for Ce(III).](molecules-23-01182-sch002){#molecules-23-01182-sch002}

![Infrared (IR) spectra for (**A**) gemifloxacin (GMFX), (**B**) glycine (Gly), (**C**) Sn(II), (**D**) Zn(II), and (**E**) Ce(III).](molecules-23-01182-g001){#molecules-23-01182-f001}

![Ultraviolet-visible (UV-Vis). Spectrum for (**A**) GMFX, (**B**) Sn(II), (**C**) Zn(II), and (**D**) Ce(III).](molecules-23-01182-g002){#molecules-23-01182-f002}

![Proton-nuclear magnetic resonance (^1^H NMR) spectra for (**A**) \[Sn(GMFX)(Gly)\]Cl~2~, (**B**) \[Zn(GMFX)(Gly)\]Cl~2~·H~2~O, and (**C**) \[Ce(GMFX)(Gly)\]SO~4~·H~2~O.](molecules-23-01182-g003){#molecules-23-01182-f003}

![Radical scavenging activity (RSA,%) of GMFX and its metal complexes derived from 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis (3-ethylbenzthiazoline-6-acid) (ABTS) assays. Bars with different letters for each method indicate means values significantly different at *p* \< 0.05 according to Tukey post hoc test. Data are expressed as the mean of three replicates ± SDs.](molecules-23-01182-g004){#molecules-23-01182-f004}
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###### 

Elemental analysis and physico-analytical data for gemifloxacin (GMFX), glycine (Gly), and its metal complexes.

  Compounds M.wt. and M.F.                      Yield%   Mp/°C   Color          Found (Calcd.) (%)   μ~eff~ (B. M.)   Λ S cm^2^ mol^−1^                                        
  --------------------------------------------- -------- ------- -------------- -------------------- ---------------- ------------------- --------------- ------------- ------ --------
  **GMFX 389.4 (C~18~H~20~FN~5~O~4~)**          \-       220     White brown    55.50 (55.52)        5.18 (5.17)      17.98 (17.99)       \-              \-            \-     47.50
  **Gly 75.07 (C~2~H~5~NO~2~)**                 \-       233     White          31.98 (32.00)        6.64 (6.66)      18.63 (18.66)       \-              \-            \-     50.77
  **(1) 619.89 (ZnC~20~H~31~N~6~O~9~FCl)**      78       310     Faint yellow   38.69 (38.71)        4.97 (5.00)      13.49 (13.55)       10.50 (10.55)   5.72 (5.72)   \-     97.58
  **(2) 655.20 (SnC~20~H~29~N~6~O~8~FCl)**      82       330     Faint brown    36.60 (36.63)        4.39 (4.42)      12.79 (12.82)       17.98 (18.11)   5.38 (5.41)   \-     86.34
  **(3) 730.10 (CeC~20~H~31~N~6~O~9~FCl~2~)**   95       340     Beige          32.82 (32.87)        4.18 (4.24)      11.42 (11.50)       19.12 (19.19)   9.70 (9.72)   2.34   150.11

Where: M.wt.: molecular weight; M.F.: molecular formula; Mp: melting point; Calcd.: calculated values; μ~eff~.: effective magnetic moment; S: siemens (Ohm^−1^).
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###### 

Infrared frequencies (cm^−1^) and tentative assignments for (**A**) GMFX, (**B**) Gly, (**C**) Sn(II), (**D**) Zn(II), and (**E**) Ce(III).

  --------------------------------------------------------------------------------------
  A        B        C         D        E         Assignments
  -------- -------- --------- -------- --------- ---------------------------------------
  3533w    3522w\   3341mbr   3545w    3375mbr   ν(O--H); H~2~O; COOH
           3478w                                 

  3156w    3133vw   3067vw    3044sh   3089vw    ν(N--H)

  3044w             3009m              3022w     

  2943s    2955m    2889w     2974m    2955m     ν(C--H); aliphatic

  2867vw   2843m    2766w     2871vw   2822vw    

  2778m    2767w    2711vw    2800m    2756w     

  2712ms   2722w              2758w    2716m     

           2712m                                 

  1732vs   1703vs   \-        \-       \-        ν(C=O); COOH

  \-       1620vs   1620vs    1622m    1624s     ν~as~(COO^−^)

  1624vs   1589s    1574s     1574s    1570vs    ν(C=N)

           1539m                                 

  1466vs   1494s    1485vs    1462vs   1485s     --CH; deformations of CH~2~

           1474s                                 

  1385m    1377s    1393s     1385vs   1393s     ν~s~(COO^−^)

  1367sh            1378w     1350sh             

  1331ms   1322m    1304ms    1300m    1308s     δ~b~(--CH~2~)

  1261vs   1285s    1269s     1269s    1265s     ν(C--O), ν(C--N) and ν(C--C)

  1223w    1211sh   1189vw    1184m    1184m     

  1188m    1172vw   1144w     1146m    1146m     

  1156m    1146ms                                

  1089m    1034s    1103m     1038ms   1107m     δ~r~(--CH~2~)

  1034s             1072sh             1034s     

                    1038m                        

  989vw    989w     989vw     945ms    945s      --CH-bend; phenyl

  968m     937ms    941ms     899m     895m      

  933m     894w     911vw     844m     829m      

  887ms    867m     829m      822w               

  833ms    833ms              800vw              

  822vw                                          

  795m     783m     779m      778w     778m      δ~b~(COO^−^)

  767vw    721s     745s      752m     748s      

  748m              710w      711m     710m      

  710m                                           

  656w     644vw    625ms     633ms    667vw     ν(M--O). ν(M--N) and ring deformation

  622m     621ms    578m      583m     629m      

  571ms    559s     544w      544w     578w      

  550vw    494ms    502m      505s     544m      

  486m     436m     478w      478sh    502m      

  478vw    406m     433w      444vw    478sh     

  436s              413w      422w     440w      
  --------------------------------------------------------------------------------------

Keys: s = strong, w = weak, v = very, m = medium, br = broad, sh = shoulder, ν = stretching, δb = bending.
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###### 

UV-Vis spectral data of the free ligand GMFX and its metal complexes.

  Assignments (nm)                   GMFX   GMFX Metal Complexes         
  ---------------------------------- ------ ---------------------- ----- ----------
  **π--π\* transitions**             326    332                    330   332
  ***n*--π\* transitions**           380    390                    388   392
  **Ligand-metal charge transfer**   \-     402                    432   420, 468
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###### 

^1^H NMR values (ppm) and tentative assignments for GMFX, Gly ligands and its metal complexes.

  GMFX         Gly      Zn(II)            Sn(II)            Ce(III)           Assignments
  ------------ -------- ----------------- ----------------- ----------------- ----------------------------------
  1.14--1.33   \-       1.29--1.32        1.20--1.33        1.14--1.33        δH.--CH~2~ and --CH cyclopropane
  2.71         2.00     2.71              2.72              2.71              δH.--^+^NH~2~
  3.32--3.36   3.59 -   3.32--3.84 4.59   3.36--3.99 4.89   3.21--3.99 4.50   δH.--CH~2~ aliphatic δH. H~2~O
  8.02--8.72   \-       8.40--8.71        8.40--8.71        8.40--8.71        δH.--CH aromatic
  11           11       \-                \-                \-                δH.--COOH
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###### 

Antibacterial activity of the studied GMFX ligand and its metal complexes compared to four synthetic antibiotics.

  Bacterial Growth Inhibition %                                                
  ------------------------------- -------------- -------------- -------------- --------------
  GMFX 10,000                     68.9 ± 0.1b    75.6 ± 0.1ab   90.0 ± 0.9ab   54.4 ± 0.2bc
  GMFX 1000                       61.1 ± 0.2bc   57.8 ± 0.3bc   86.0 ± 0.4b    43.3 ± 0.1c
  GMFX 100                        55.5 ± 0.6c    50.0 ± 0.2c    85.0 ± 0.6b    37.8 ± 0.1cd
  Sn--GMFX 10,000                 82.2 ± 0.3a    82.2 ± 0.2a    97.0 ± 0.7a    56.7 ± 0.1bc
  Sn--GMFX 1000                   65.6 ± 0.2b    62.2 ± 0.2bc   86.0 ± 0.5b    44.4 ± 0.1c
  Sn--GMFX 100                    52.2 ± 0.1c    52.2 ± 0.1c    84.0 ± 0.6b    38.9 ± 0.2cd
  Zn--GMFX 10,000                 80.0 ± 0.1a    83.3 ± 0.2a    95.0 ± 0.8a    57.8 ± 0.2bc
  Zn--GMFX 1000                   65.6 ± 0.1b    60.0 ± 0.2bc   89.0 ± 0.6ab   48.9 ± 0.2c
  Zn--GMFX 100                    52.0 ± 0.4c    51.1 ± 0.2c    85.0 ± 0.4b    37.8 ± 0.3cd
  Ce--GMFX 10,000                 83.0 ± 0.3a    72.2 ± 0.2b    98.0 ± 0.6a    61.1 ± 0.2b
  Ce--GMFX 1000                   60.0 ± 0.2bc   60.0 ± 0.3bc   91.0 ± 0.0ab   41.1 ± 0.1c
  Ce--GMFX 100                    50.0 ± 0.2c    42.2 ± 0.1d    92.0 ± 0.0ab   30.0 ± 0.1d
  Ampicillin 100 µg/mL            80.0 ± 0.3a    74.4 ± 0.3ab   98.0 ± 0.5a    32.2 ± 0.1cd
  Streptomycin 50 µg/mL           51.1 ± 0.1c    55.6 ± 0.1bc   96.0 ± 0.7a    53.3 ± 0.1bc
  Kanamycin 50 µg/mL              68.9 ± 0.2b    71.1 ± 0.2b    98.0 ± 0.4a    57.8 ± 0.1bc
  Cephaloxacin 30 µg/mL           53.3 ± 0.2c    60.0 ± 0.2bc   93.0 ± 0.9a    84.0 ± 0.14a
  Control KB                      0.0 ± 0.0d     0.0 ± 0.0e     0.0 ± 0.0c     0.00 ± 0.0e

Where: GMFX: gemifloxacin; Sn: Tin; Zn: Zinc; Ce: Cerium; KB: King's B media. Values are recorded as the mean of bacterial inhibition percentage (%) from three replicates ± SDs. Values followed by the different letter in each vertical column for each bacterium are significantly different according to Tukey post hoc test at *p* \< 0.05.
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###### 

Antifungal activity of GMFX and its metal complexes.

                                            Fungal Mycelium Growth Inhibition %                                                   
  ------------------------- --------------- ------------------------------------- --------------- --------------- --------------- --------------
  GMFX                      1000            78.1 ± 0.22a                          71.9 ± 0.04ab   69.0 ± 0.13a    91.9 ± 0.13a    95.3 ± 0.11a
  500                       66.3 ± 0.18b    34.4 ± 0.67b                          63.4 ± 0.13ab   86.3 ± 0.09ab   83.1 ± 0.13b    
  250                       50.0 ± 0.0c     0.0 ± 0.0d                            45.0 ± 0.36c    60.6 ± 0.13b    76.3 ± 0.09b    
  Sn--GMFX                  1000            28.1 ± 0.22d                          6.3 ± 0.45cd    56.9 ± 0.09b    51.3 ± 0.09c    76.3 ± 0.09b
  500                       6.3 ± 0.0e      0.0 ± 0.0d                            53.1 ± 0.09bc   45.6 ± 0.13cd   69.4 ± 0.13bc   
  250                       0.0 ± 0.0f      0.0 ± 0.0d                            48.4 ± 0.22bc   37.5 ± 0.0d     63.1 ± 0.04bc   
  Zn--GMFX                  1000            15.6 ± 0.22de                         26.9 ± 0.31b    65.6 ± 0.09ab   51.3 ± 0.09c    90.6 ± 0.13a
  500                       7.5 ± 0.09e     18.8 ± 1.34bc                         64.4 ± 0.09ab   45.0 ± 0.09cd   75.0 ± 0.18b    
  250                       0.0 ± 0.0f      11.3 ± 0.18c                          58.8 ± 0.36b    37.5 ± 0.0d     64.4 ± 0.13bc   
  Ce--GMFX                  1000            43.1 ± 0.3cd1                         21.9 ± 0.67b    64.4 ± 0.09ab   50.0 ± 0.0c     71.3 ± 0.09b
  500                       18.1 ± 0.13d    12.5 ± 0.89c                          63.8 ± 0.18ab   37.5 ± 0.0d     65.6 ± 0.13bc   
  250                       3.1 ± 0.22e     6.3 ± 0.45cd                          41.6 ± 0.58c    37.5 ± 0.0d     61.3 ± 0.09c    
  Azoxystrobin 1 µL/mL      26.9 ± 0.13d    26.9 ± 0.13d                          80.0 ± 0.09a    72.2 ± 0.13a    58.1 ± 0.13b    
  Cycloheximide 0.1 µL/mL   14.4 ± 0.13de   14.4 ± 0.13de                         10.6 ± 0.31c    49.7 ± 0.31bc   46.9 ± 0.22cd   
  PDA ctrl                  0.00 ± 0.0f     0.00 ± 0.0f                           0.0 ± 0.0d      0.0 ± 0.0cd     0.0 ± 0.0d      

Where: GMFX: gemifloxacin; Sn: Tin; Zn: Zinc; Ce: Cerium; PDA: Potato Dextrose Agar. Values are recorded as the mean of fungal mycelium growth inhibition (%) from three replicates ± SDs. Values followed by the different letter in each vertical column for each fungus are significantly different according to Tukey post hoc test at *p* \< 0.05.
